In the present study, we first examined the expression of Nm23H1 and CLDN1 in 74 surgical ESCC samples by immunohistochemistry (IHC) to verify their clinicopathologic significance. This evidence concerns the gene CLDN1 and esophageal squamous cell carcinoma.